Oxidative stimuli affect polyglutamine aggregation and cell death in human mutant ataxin-1-expressing cells

Neurosci Lett. 2003 Sep 4;348(1):21-4. doi: 10.1016/s0304-3940(03)00657-8.

Abstract

Spinocerebellar ataxia 1 (SCA1), one of the inherited polyglutamine neurodegenerative diseases, is associated with intracellular aggregates. However, the process of aggregate formation and the factors that influence aggregation remain unclear. Here, we show that oxidative stimuli and alteration of the cellular redox state significantly affect aggregation and cell death in cells expressing mutant ataxin-1, the SCA gene product. Treatment of cells with buthionine sulfoximine, hydrogen peroxide or t-butylhydroperoxide increased the formation of mutant ataxin-1 aggregates, but treatment with the anti-oxidant, N-acetylcysteine (NAC), decreased aggregate formation. Oxidative damage of mutant ataxin-1 protein increased its recruitment in nuclear aggregates and increased cell death. However, NAC treatments reduced cell death and the number of cells with abnormal morphology. Our results might give insight into the mechanism whereby polyglutamine proteins aggregate and suggest that treatment of appropriate antioxidant reagents might prevent progression of SCA1 and other polyglutamine diseases.

Publication types

  • Comparative Study

MeSH terms

  • Acetylcysteine / pharmacology
  • Animals
  • Ataxin-1
  • Ataxins
  • Buthionine Sulfoximine / pharmacology
  • Cell Aggregation / physiology*
  • Cell Death / physiology*
  • Fluorescent Antibody Technique / methods
  • Free Radical Scavengers / pharmacology
  • Green Fluorescent Proteins
  • HeLa Cells
  • Humans
  • Hydrogen Peroxide / pharmacology
  • Immunoblotting / methods
  • Luminescent Proteins / metabolism
  • Mutation
  • Nerve Tissue Proteins / biosynthesis
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / physiology*
  • Nuclear Proteins / biosynthesis
  • Nuclear Proteins / genetics
  • Nuclear Proteins / physiology*
  • Oxidants / pharmacology
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology*
  • Peptides / immunology
  • Peptides / metabolism*
  • Radiation-Protective Agents / pharmacology
  • Rats
  • Time Factors
  • Transfection
  • tert-Butylhydroperoxide / pharmacology

Substances

  • ATXN1 protein, human
  • Ataxin-1
  • Ataxins
  • Atxn1 protein, rat
  • Free Radical Scavengers
  • Luminescent Proteins
  • Nerve Tissue Proteins
  • Nuclear Proteins
  • Oxidants
  • Peptides
  • Radiation-Protective Agents
  • Green Fluorescent Proteins
  • polyglutamine
  • Buthionine Sulfoximine
  • tert-Butylhydroperoxide
  • Hydrogen Peroxide
  • Acetylcysteine